GlassScriptPhysician profile
Jonathan S Grinstein
NPI 1396065249
$127,585.94
in general payments reported to CMS, 2019-2025
17 companies · $48K in 2025
The $48K reported for 2025 was more than what 92% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,217 · 2020: $2,875 · 2021: $14K · 2022: $11K · 2023: $13K · 2024: $38K · 2025: $48K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $64K · Travel and Lodging: $19K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $8,938 · Food and Beverage: $5,494 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $63,634.13 |
| Travel and Lodging | $18,710.70 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $8,937.50 |
| Food and Beverage | $5,494.49 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,025.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $119,248.67 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Freestyle Libre Pro, Cardiomems |
| Medtronic, INC. | $4,494.56 | 2021-2022 | |
| Medtronic Vascular, INC. | $1,153.38 | 2019-2020 | |
| Abiomed | $824.77 | 2021-2025 | Impella |
| Cvrx, INC. | $732.26 | 2021-2025 | Barostim Neo System |
| Endotronix, INC. | $220.29 | 2023-2025 | Cordella Pulomonary Artery Pressure Sensor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $195.28 | 2019-2024 | Lifevest |
| Pfizer INC. | $182.82 | 2019-2023 | |
| Nuwellis, INC. | $138.42 | 2023 | Aquadex Smartflow Console |
| Novartis Pharmaceuticals Corporation | $119.86 | 2020-2025 | |
| Procyrion, INC. | $88.51 | 2022-2024 | Aortix System |
| Astrazeneca Pharmaceuticals LP | $57.96 | 2022-2023 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $34.07 | 2023-2024 | Camzyos |
| Lexicon Pharmaceuticals, INC. | $32.92 | 2023 | Inpefa |
| Takeda Pharmaceuticals U.S.A., INC. | $23.33 | 2023 | Livtencity |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akcea Therapeutics, INC. | $21.39 | 2019 | |
| Merck Sharp & Dohme LLC | $17.45 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Grinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.